Source document or public record
FDA 510(k) K223591 — cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® System
FDA 510(k) index record K223591. Device: cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® System. Applicant as listed: Roche Molecular Systems, Inc.. Decision date: 2023-07-27.
Source
"device_name": "cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® System"
This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.
Review and references
Automated FDA record verification
2026-10-20
2026-10-20
professional use
FDA 510(k) public index record K223591.
Device name: cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® System. Applicant as listed: Roche Molecular Systems, Inc..
Decision date: 2023-07-27. Decision wording: Substantially Equivalent.
Product code: QOF. Regulation: 21 CFR 866.3981. Medical specialty: Microbiology.
This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.
Interested in these solutions?
Submit a sourcing request with the assays, volumes, and timeline of your own project.